Skip to main content
SpringerLink
Log in

Endoscopic Treatment of Vesicoureteral Reflux

Pediatric Surgery

  • 8 Accesses

Abstract

Vesicoureteral reflux (VUR) is one of the most common urological abnormalities, affecting 1–2% of the pediatric population and 25–40% of children presenting with urinary tract infection (UTI). The association of VUR, UTI, and renal parenchymal damage is widely recognized. Therefore, timely intervention is essential to prevent recurrent urinary tract infections and reduce the risk of permanent renal parenchymal damage and to minimize sequelae of reflux nephropathy. Since its first clinical application in the early 1980s and the approval of dextranomer/hyaluronic acid (Deflux®) by the US Food and Drug Administration (FDA) in 2001 as an acceptable tissue augmenting substance for subureteral injection, endoscopic treatment of VUR has gained worldwide popularity and is currently the first-line therapy for many infants and children with primary reflux. Over the years, multiple studies have demonstrated safety and long-term efficacy of this minimally invasive outpatient procedure, which has success rates of 77–83% after the first injection and can easily be repeated in cases of failure, with a high rate of subsequent resolution. Ureterovesical junction obstruction after endoscopic correction of VUR has been reported in less than 1% of treated cases and appears to be independent of the tissue augmenting substance, volume, and injection technique.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Al Hindi S, Mubarak M, Al AH. High-grade vesicoureteral reflux in infants: Our experience with endoscopicsubureteric injections. Urologia. 2022;89(1):120–5.

    Google Scholar 

  • Baybikov R, Sizonov V, Bondarenko S, Dolgov B, Dubrov V, Kagantsov I, et al. Do the type of bulking agents and injection method have any influence on the incidence of ureteral obstruction by endoscopic treatment of reflux? J Pediatr Urol. 2015;11(Suppl 4)

    Google Scholar 

  • Ben-Meir D, Morgenstern S, Sivan B, Efrat R, Livne PM. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux. J Urol. 2012;188(1):258–61.

    Google Scholar 

  • Ben-Meir D, Bahouth Z, Halachmi S. Late-onset Uretero-vesical Junction Obstruction Following Endoscopic Injection of Bulking Material for the Treatment of Vesico-ureteral Reflux. Urology. 2017;101:60–2.

    Google Scholar 

  • Benoit RM, Peele PB, Docimo SG. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management. J Urol. 2006;176(4 Pt 1):1588–92.

    Google Scholar 

  • Brandström P, Nevéus T, Sixt R, Stokland E, Jodal U, Hansson S. The Swedish reflux trial in children: IV. Renal damage. J Urol. 2010a;184(1):292–7.

    Google Scholar 

  • Brandström P, Esbjörner E, Herthelius M, Swerkersson S, Jodal U, Hansson S. The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol. 2010b;184(1):286–91.

    Google Scholar 

  • Capozza N, Lais A, Matarazzo E, Nappo S, Patricolo M, Caione P. Treatment of vesico-ureteric reflux: a new algorithm based on parental preference. BJU Int. 2003;92(3):285–8.

    Google Scholar 

  • Cara-Fuentes G, Gupta N, Garin EH. The RIVUR study: a review of its findings. Pediatr Nephrol. 2015;30(5):703–6.

    Google Scholar 

  • Diamond DA, Mattoo TK. Endoscopic treatment of primary vesicoureteral reflux. N Engl J Med. 2012;366(13):1218–26.

    Google Scholar 

  • Elder JS, Diaz M, Caldamone AA, Cendron M, Greenfield S, Hurwitz R, et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol. 2006;175(2):716–22.

    Google Scholar 

  • Friedmacher F, Puri P. Ureteral Obstruction After Endoscopic Treatment of Vesicoureteral Reflux: Does the Type of Injected Bulking Agent Matter? Curr Urol Rep. 2019;20(9):49.

    Google Scholar 

  • Friedmacher F, Colhoun E, Puri P. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results. J Urol. 2018;200(3):650–5.

    Google Scholar 

  • Fuentes S, Gómez-Fraile A, Carrillo-Arroyo I, Tordable-Ojeda C, Cabezalí-Barbancho D. Endoscopic Treatment of Vesicoureteral Reflux in Infants. Can We Do It and Should We Do It? Urology. 2017;110:196–200.

    Google Scholar 

  • García-Aparicio L, Rovira J, Blazquez-Gomez E, García-García L, Giménez-Llort A, Rodo J, et al. Randomized clinical trial comparing endoscopic treatment with dextranomer hyaluronic acid copolymer and Cohen's ureteral reimplantation for vesicoureteral reflux: long-term results. J Pediatr Urol. 2013a;9(4):483–7.

    Google Scholar 

  • García-Aparicio L, Rodo J, Palazon P, Martín O, Blázquez-Gómez E, Manzanares A, et al. Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage. J Pediatr Urol. 2013b;9(4):493–7.

    Google Scholar 

  • Gargollo PC, Paltiel HJ, Rosoklija I, Diamond DA. Mound calcification after endoscopic treatment of vesicoureteral reflux with autologous chondrocytes--a normal variant of mound appearance? J Urol. 2009;181(6):2702–7.

    Google Scholar 

  • Hayn MH, Smaldone MC, Ost MC, Docimo SG. Minimally invasive treatment of vesicoureteral reflux. Urol Clin North Am. 2008;35(3):477–88.

    Google Scholar 

  • Holmdahl G, Brandström P, Läckgren G, Sillén U, Stokland E, Jodal U, et al. The Swedish reflux trial in children: II. Vesicoureteral reflux outcome. J Urol. 2010;184(1):280–5.

    Google Scholar 

  • Hsieh MH, Madden-Fuentes RJ, Lindsay NE, Roth DR. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon. Urology. 2010a;76(1):199–203.

    Google Scholar 

  • Hsieh MH, Madden-Fuentes RJ, Bayne A, Munch E, Wildenfels P, Alexander SJ, et al. Cross-sectional evaluation of parental decision making factors for vesicoureteral reflux management in children. J Urol. 2010b;184(4 Suppl):1589–93.

    Google Scholar 

  • Hunziker M, Puri P. Familial vesicoureteral reflux and reflux related morbidity in relatives of index patients with high grade vesicoureteral reflux. J Urol. 2012;188(4 Suppl):1463–6.

    Google Scholar 

  • Hunziker M, Mohanan N, D'Asta F, Puri P. Incidence of febrile urinary tract infections in children after successful endoscopic treatment of vesicoureteral reflux: a long-term follow-up. J Pediatr. 2012;160(6):1015–20.

    Google Scholar 

  • Hunziker M, Mohanan N, Puri P. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems. J Urol. 2013;189(5):1876–81.

    Google Scholar 

  • Kirsch AJ, Arlen AM. Evaluation of new Deflux administration techniques: intraureteric HIT and Double HIT for the endoscopic correction of vesicoureteral reflux. Expert Rev Med Devices. 2014;11(5):439–46.

    Google Scholar 

  • Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC. The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol. 2004;171(6 Pt 1):2413–6.

    Google Scholar 

  • Knudson MJ, Austin JC, McMillan ZM, Hawtrey CE, Cooper CS. Predictive factors of early spontaneous resolution in children with primary vesicoureteral reflux. J Urol. 2007;178(4 Pt 2):1684–8.

    Google Scholar 

  • Kobelt G, Canning DA, Hensle TW, Läckgren G. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol. 2003;169(4):1480–4.

    Google Scholar 

  • Läckgren G, Wåhlin N, Sköldenberg E, Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol. 2001;166(5):1887–92.

    Google Scholar 

  • Nepple KG, Knudson MJ, Cooper CS, Austin JC. Symptomatic calcification of subureteral collagen ten years after injection. Urology. 2007;69(5):982.e1–2.

    Google Scholar 

  • Noe HN. Calcification in a Deflux bleb thought to be a ureteral calculus in a child. J Pediatr Urol. 2008;4(1):88–9.

    Google Scholar 

  • O'Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed). 1984;289(6436):7–9.

    Google Scholar 

  • Ogan K, Pohl HG, Carlson D, Belman AB, Rushton HG. Parental preferences in the management of vesicoureteral reflux. J Urol. 2001;166(1):240–3.

    Google Scholar 

  • Palagiri AV, Dangle PP. Distal ureteral calcification secondary to deflux injection: a reality or myth? Urology. 2011;77(5):1217–9.

    Google Scholar 

  • Peters C, Rushton HG. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol. 2010;184(1):265–73.

    Google Scholar 

  • Peters CA, Skoog SJ, Arant BS Jr, Copp HL, Elder JS, Hudson RG, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol. 2010;184(3):1134–44.

    Google Scholar 

  • Puri P. Endoscopic correction of primary vesicoureteric reflux by subureteric injection of polytetrafluoroethylene. Lancet. 1990;335:1320–2.

    Google Scholar 

  • Puri P, O'Donnell B. Correction of experimentally produced vesicoureteric reflux in the piglet by intravesical injection of Teflon. Br Med J (Clin Res Ed). 1984;289:5–7.

    Google Scholar 

  • Puri P, Mohanan N, Menezes M, Colhoun E. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid. J Urol. 2007;178(4 Pt 2):1714–6. discussion 1717

    Google Scholar 

  • Puri P, Gosemann JH, Darlow J, Barton DE. Genetics of vesicoureteral reflux. Nat Rev Urol. 2011;8(10):539–52.

    Google Scholar 

  • Puri P, Kutasy B, Colhoun E, Hunziker M. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux. J Urol. 2012;188(4 Suppl):1485–9.

    Google Scholar 

  • Routh JC, Reinberg Y, Ashley RA, Inman BA, Wolpert JJ, Vandersteen DR, et al. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. J Urol. 2007;178(4 Pt 2):1702–5.

    Google Scholar 

  • Routh JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics. 2010a;125(5):1010–9.

    Google Scholar 

  • Routh JC, Nelson CP, Graham DA, Lieu TA. Variation in surgical management of vesicoureteral reflux: influence of hospital and patient factors. Pediatrics. 2010b;125(3):e446–51.

    Google Scholar 

  • Rubenwolf PC, Ebert AK, Ruemmele P, Rösch WH. Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series. Urology. 2013;81(3):659–62.

    Google Scholar 

  • Sargent MA. What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol. 2000;30(9):587–93.

    Google Scholar 

  • Sjöström S, Sillén U, Jodal U, Sameby L, Sixt R, Stokland E. Predictive factors for resolution of congenital high grade vesicoureteral reflux in infants: results of univariate and multivariate analyses. J Urol. 2010;183(3):1177–84.

    Google Scholar 

  • Skoog SJ, Peters CA, Arant BS Jr, Copp HL, Elder JS, Hudson RG, et al. Pediatric Vesicoureteral Reflux Guidelines Panel Summary Report: Clinical Practice Guidelines for Screening Siblings of Children With Vesicoureteral Reflux and Neonates/Infants With Prenatal Hydronephrosis. J Urol. 2010;184(3):1145–51.

    Google Scholar 

  • Stenbäck A, Olafsdottir T, Sköldenberg E, Barker G, Stenberg A, Läckgren G. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study. J Pediatr Urol. 2020;16(3):328.e1–9.

    Google Scholar 

  • Swerkersson S, Jodal U, Sixt R, Stokland E, Hansson S. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children. J Urol. 2007;178(2):647–51.

    Google Scholar 

  • Tekgül S, Riedmiller H, Hoebeke P, Kočvara R, Nijman RJ, Radmayr C, et al. EAU guidelines on vesicoureteral reflux in children. Eur Urol. 2012;62(3):534–42.

    Google Scholar 

  • Watters ST, Sung J, Skoog SJ. Endoscopic treatment for vesicoureteral reflux: how important is technique? J Pediatr Urol. 2013;9(6 Pt B):1192–7.

    Google Scholar 

  • Williams G, Fletcher JT, Alexander SI, Craig JC. Vesicoureteral reflux. J Am Soc Nephrol. 2008;19(5):847–62.

    Google Scholar 

  • Yap TL, Chen Y, Nah SA, Ong CC, Jacobsen A, Low Y. STING versus HIT technique of endoscopic treatment for vesicoureteral reflux: A systematic review and meta-analysis. J Pediatr Surg. 2016;51(12):2015–20.

    Google Scholar 

  • Yucel S, Gupta A, Snodgrass W. Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol. 2007;177(4):1505–9.

    Google Scholar 

  • Zerin JM, Ritchey ML, Chang AC. Incidental vesicoureteral reflux in neonates with antenatally detected hydronephrosis and other renal abnormalities. Radiology. 1993;187(1):157–60.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frankfurt, Germany

    Florian Friedmacher

  2. Beacon Hospital, University College Dublin, Dublin, Ireland

    Prem Puri

Authors
  1. Florian Friedmacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prem Puri
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Beacon Hospital, University College Dublin, Dublin, Ireland

    Prem Puri

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer-Verlag GmbH Germany, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Friedmacher, F., Puri, P. (2022). Endoscopic Treatment of Vesicoureteral Reflux. In: Puri, P. (eds) Pediatric Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38482-0_179-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-38482-0_179-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-38482-0

  • Online ISBN: 978-3-642-38482-0

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Endoscopic Treatment of Vesicoureteral Reflux
    Published:
    20 July 2022

    DOI: https://doi.org/10.1007/978-3-642-38482-0_179-2

  2. Original

    Endoscopic Treatment of Vesicoureteral Reflux
    Published:
    28 June 2022

    DOI: https://doi.org/10.1007/978-3-642-38482-0_179-1

Search

Navigation